Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Pillar Clinical Research, LLC
mi
from
Dallas, TX
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Family Psychiatry of the Woodlands
mi
from
The Woodlands, TX
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Family Psychiatry of the Woodlands
mi
from
The Woodlands, TX
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Department of Psychiatry, University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Department of Psychiatry, University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Frontier Institute
mi
from
Spokane, WA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Frontier Institute
mi
from
Spokane, WA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Accurate Clinical Trials
mi
from
Kissimme, FL
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Accurate Clinical Trials
mi
from
Kissimme, FL
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Florida Clinical Research Center LLC
mi
from
Maitland, FL
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Medical Research Group of Central Florida
mi
from
Orange City, FL
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Medical Research Group of Central Florida
mi
from
Orange City, FL
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Psychiatric Care and Research Center
mi
from
O'Fallon, MO
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Psychiatric Care and Research Center
mi
from
O'Fallon, MO
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
CHU Clermont-Ferrand - CMP B
mi
from
Clermont-Ferrand Cedex 1,
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
CHU Clermont-Ferrand - CMP B
mi
from
Clermont-Ferrand Cedex 1,
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Woodland Northwest Research, LLC
mi
from
Springdale, AR
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Woodland Northwest Research, LLC
mi
from
Springdale, AR
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
World Wide Research Centers Inc.
mi
from
Murrietta, CA
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
World Wide Research Centers Inc.
mi
from
Murrietta, CA
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
University of Cincinnati, Dept. of Psychiatry & Behavioral Neuroscience
mi
from
Cincinnati, OH
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
University of Cincinnati, Dept. of Psychiatry & Behavioral Neuroscience
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
CRI Worldwide, LLC
mi
from
Philadelphia, PA
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
CRI Worldwide, LLC
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Aspen Clinical Research, LLC
mi
from
Orem, UT
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Aspen Clinical Research, LLC
mi
from
Orem, UT
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Segal Institute for Clinical Research
mi
from
Ft. Lauderdale, FL
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Segal Institute for Clinical Research
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Miami Children's Hospital
mi
from
South Miami, FL
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Miami Children's Hospital
mi
from
South Miami, FL
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Birmingham Psychiatry Pharmaceutical
mi
from
Birmingham, AL
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Birmingham Psychiatry Pharmaceutical
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Summit Research Group
mi
from
Little Rock, AR
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Summit Research Group
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Comprehensive NeuroScience
mi
from
Cerritos, CA
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Comprehensive NeuroScience
mi
from
Cerritos, CA
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Collaborative Neuro Science Network, Inc.
mi
from
Garden Grove, CA
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Collaborative Neuro Science Network, Inc.
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Optimum Health Services
mi
from
La Mesa, CA
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Optimum Health Services
mi
from
La Mesa, CA
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
California Clinical Trials
mi
from
San Diego, CA
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
California Clinical Trials
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
CNRI - San Diego, LLC
mi
from
San Diego, CA
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
CNRI - San Diego, LLC
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Pacific Clinical Research
mi
from
Upland, CA
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Pacific Clinical Research
mi
from
Upland, CA
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Comprehensive Neuroscience, Inc.
mi
from
Washington,
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Comprehensive Neuroscience, Inc.
mi
from
Washington,
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
The Segal Institute of Clinical Research
mi
from
North Miami, FL
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
The Segal Institute of Clinical Research
mi
from
North Miami, FL
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Segal Institute
mi
from
North Miami, FL
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Segal Institute
mi
from
North Miami, FL
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
University of South Florida, Department of Psychiatry and Behavioral Medicine
mi
from
Tampa, FL
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
University of South Florida, Department of Psychiatry and Behavioral Medicine
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Atlanta Center for Medical Research
mi
from
Atlanta, GA
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Comprehensive Neuroscience, Inc.
mi
from
Hoffman Estates, IL
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Comprehensive Neuroscience, Inc.
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Robert Lynn Horne, MD, Suite 4
mi
from
Las Vegas, NV
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Robert Lynn Horne, MD, Suite 4
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
CNS Research Institute
mi
from
Clementon, NJ
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
CNS Research Institute
mi
from
Clementon, NJ
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Quantum Clinical Services Group
mi
from
Philadelphia, PA
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Quantum Clinical Services Group
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Community Clinical Research
mi
from
Austin, TX
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Community Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Future Search Trials
mi
from
Austin, TX
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Future Search Trials
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Claghorn-Lesem Research Clinic
mi
from
Bellaire, TX
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Claghorn-Lesem Research Clinic
mi
from
Bellaire, TX
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
InSite Clinical Research LLC
mi
from
DeSoto, TX
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
InSite Clinical Research LLC
mi
from
DeSoto, TX
Click here to add this to my saved trials
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated:  3/10/2016
CBH Health, L.L.C - Dominion Hospital
mi
from
Falls Church, VA
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia
Status: Enrolling
Updated: 3/10/2016
CBH Health, L.L.C - Dominion Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated:  3/11/2016
K & S Professional Research Services
mi
from
Little Rock, AR
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated: 3/11/2016
K & S Professional Research Services
mi
from
Little Rock, AR
Click here to add this to my saved trials
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated:  3/11/2016
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated: 3/11/2016
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated:  3/11/2016
Clinical Pharmacological Studies, Inc.
mi
from
Cerritos, CA
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated: 3/11/2016
Clinical Pharmacological Studies, Inc.
mi
from
Cerritos, CA
Click here to add this to my saved trials
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated:  3/11/2016
Comprehensive NeuroScience
mi
from
Cerritos, CA
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated: 3/11/2016
Comprehensive NeuroScience
mi
from
Cerritos, CA
Click here to add this to my saved trials
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated:  3/11/2016
Clinical Innovations, Inc
mi
from
Costa Mesa, CA
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated: 3/11/2016
Clinical Innovations, Inc
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated:  3/11/2016
Synergy Escondido
mi
from
Escondido, CA
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated: 3/11/2016
Synergy Escondido
mi
from
Escondido, CA
Click here to add this to my saved trials
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated:  3/11/2016
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated: 3/11/2016
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated:  3/11/2016
Apostle Clinical Trials, Inc
mi
from
Long Beach, CA
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Status: Enrolling
Updated: 3/11/2016
Apostle Clinical Trials, Inc
mi
from
Long Beach, CA
Click here to add this to my saved trials